By moving beyond adherence and drug interactions to a holistic, outcomes-driven approach, health systems and providers can redefine how medication is used — not as a rigid protocol but as a dynamic, patient-centered tool for achieving better health. The post Medication Adherence and Deprescribing Programs Aren’t Enough for Today’s Polypharmacy Patients appeared first on MedCity…
This KFF analysis demonstrates the impact exclusion of Planned Parenthood from Medicaid and the Title X funding freeze may have low-income and uninsured individuals who get their family planning care at Planned Parenthood.
In recent years, states across the Mountain West have passed laws that limit doctors from providing transgender children with certain kinds of gender-affirming care, from prohibitions on surgery to bans on puberty blockers and hormones. Colorado families say their state was a haven for those health services for a long time, but following executive orders…
At a swim meet just outside St. Louis, heads turned when a team of young swimmers walked through the rec center with their parents in tow. A supportive mom kept her eye on the clock while the Makos Swim Team athletes tucked their natural curls, braids, and locs into yellow swimming caps. In the bleachers,…
By MICHAEL MILLENSON “The New Yorker House Style Joins The Internet Age” announced the magazine’s daily newsletter under the byline of Andrew Boynton, whose appropriately old-fashioned title was “Head of Copy.” Among the alterations Boynton acknowledged readers might feel “long overdue,” were “Internet” becoming “internet,” “Web site” consolidating to “website” and “cell phone” becoming “cellphone.”…
Cigna Healthcare ranks highest among commercial health plans when it comes to digital experience, while UPMC Health Plan ranks highest among Medicare Advantage plans, according to J.D. Power. The post Which Health Plans Take the Lead in Member Digital Experience? appeared first on MedCity News.
The combination of Bristol Myers Squibb cancer drugs Opdivo and Yervoy landed FDA approvals for the first-line treatment of colorectal cancer and hepatocellular carcinoma. Several other products also expanded their approved uses in our recap of recent regulatory news. The post BMS Immunotherapy Combo Gets Two FDA Nods for GI Cancers in Span of a…
Even as studies and personal experiences repeatedly reflect the effectiveness of MOUD, a stigma about this approach and the medication persists, complicating efforts to help more people treat their opioid use disorders. The post Stigma Against Addiction Medication Limits Our Ability to End the Opioid Epidemic appeared first on MedCity News.
At Medicarians 2025, MedCity News Editor-in-Chief Arundhati Parmar explored the state of AgeTech venture capital with three investors. The panelists agreed that despite growing clear opportunities, the AgeTech market currently lacks the dedicated funding, proven business models and major success stories needed for it to take off. The post Where Does AgeTech Investment Stand?: VCs…
The goal of the Two-Midnight Rule, originally introduced under traditional Medicare Part A, was to reduce hospital admissions and to ensure the appropriate use of inpatient versus outpatient observation status. Here are some challenges and best practices. The post Navigating Medicare Advantage Compliance One Year After the Two-Midnight Rule appeared first on MedCity News.